Although we observed a group of publications regarding the influence of XPA rs1800975 on the risk of certain specific cancers, such as lung cancer [69, 70], head and neck cancer [71], breast cancer [72], and digestive system cancer [73, 74], the evaluation strategies, study number and statistical power differed. This evidence concerns the gene XPA and breast carcinoma.